Shots:

• Labcorp acquires the Vectra RA test from Myriad Genetics along with other operating assets and IP for $150M in cash. The transaction is expected to close in Q3’21
• The divestiture of Myriad auto immune’s Vectra testing business allow Labcorb to bolster its rheumatology and autoimmune portfolios
• Vectra is a non-invasive- blood-based test that analyzes 12 biomarkers to measure RA disease activity. It has been used by ~1M patients to understand their RA disease activity

  Ref: Businesswire | Image: Wikipedia